#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study on Sumatriptan and Rimegepant for Treating Nitroglycerin-Induced Headaches in Patients with Episodic Migraine

    Recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • Study on Rimegepant for Preventing Migraines in Children and Teens Aged 6 to 17

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Poland Spain

  • Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland Portugal Spain

  • Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine

    Recruiting

    2 1
    Investigated drugs:
    Czechia Denmark Germany Hungary Italy The Netherlands +2

  • Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1 1
    Investigated drugs:
    Poland Spain

  • Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland Spain Sweden

  • Study on Atorvastatin for Preventing Chronic Migraine in Adults

    Recruiting

    2 1 1 1
    Investigated drugs:
    Norway

  • Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France Hungary Italy The Netherlands +4

  • Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

    Recruiting

    3 1 1
    Investigated drugs:
    Belgium Denmark France Hungary Italy The Netherlands +5

  • A study to evaluate the safety and effectiveness of omalizumab in adults with episodic migraine

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Norway